Diuretics are recommended as first-line antihypertensive treatment in elderly patients. Although attention is usually paid to prevent hypokalaemia with diuretic therapy, risk of hyponatraemia is often ignored. We performed this study to characterise hypertensive patients at increased risk to develop hyponatraemia. We reviewed charts of hypertensive patients hospitalised in Chaim Sheba Medical Center for hyponatraemia from 1990 to 1997. Patients with other causes of hyponatraemia were excluded. The General Practice Maccabi database was used to estimate age and sex distribution of patients prescribed diuretics for hypertension. We identified 180 hypertensive patients (149 F, 31 M; mean age 76.4 ± 9.2 years) hospitalised because of hyponatraemia. Across all age groups, odds ratio (OR) to develop hyponatraemia was three times higher for women vs men (OR 3.10, 95% confidence interval (CI): 2.07-4.67). One hundred
Introduction
Diuretics are recommended as the first drug of choice in hypertension mainly in the elderly. [1] [2] [3] These drugs reduce cardiovascular morbidity and mortality and all-cause mortality in elderly hypertensive patients. 3 Much attention has been paid to diuretics induced hypokalaemia, 4, 5 and a combination of low-dose hydrochlorothiazide with potassium sparing diuretic has been recommended to lower the risk of sudden cardiac death. 6 Less attention has been paid to other metabolic alterations such as hyponatraemia, hyperglycaemia, hyperuricaemia, hypercalcaemia and hypercholesterolaemia. Clinically significant changes in serum sodium were not reported in a review of 15 studies that evaluated the safety and efficacy of low-dose hy-drochlorothiazide. 7 However, in the Systolic Hypertension in the Elderly Program (SHEP) study, 2 4.1% of the elderly hypertensive patients treated with low-dose chlorthalidone developed serum sodium levels р130 mmol/L. Hyponatraemia may develop insidiously and can cause significant morbidity such as lethargy, confusion, coma and even death. [8] [9] [10] [11] Previous studies reported that hyponatraemia usually developed shortly after diuretic initiation, and even that the use of a single-dose of a thiazide diuretic may predict the development of hyponatraemia. 12, 13 Since diuretics are widely used in hypertension, it is important to identify patients who are at increased risk to develop hyponatraemia. This study was therefore conducted to characterise the clinical findings of the patients who had developed diuretic induced hyponatraemia. To accomplish this study we reviewed all the charts of patients hospitalised with hyponatraemia during the years 1990-1997 in the Chaim Sheba Medical Center.
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Methods
Data analysis
The records of all patients who were hospitalised during the years 1990-1997 in the Chaim Sheba Medical Center with a diagnosis of hyponatraemia were meticulously reviewed. Hyponatraemia was defined as serum sodium concentration on admission below 135 mmol/L. Patients who had other possible causes for hyponatraemia such as congestive heart failure, cirrhosis, hypothyroidism, Addison's disease, nephrotic syndrome, and uncontrolled diabetes mellitus, were excluded from the analysis. Also excluded were patients with diarrhoea and patients with inappropriate secretion of antidiuretic hormone. Only patients who were receiving diuretic treatment for hypertension were included in the analysis.
For all hypertensive patients with diureticinduced hyponatraemia we extracted the following parameters: age, sex, drugs used, dose and duration of drugs used, associated diseases, concomitant medications, clinical presentation, and laboratory findings on admission. In addition we recorded the gender ratio of the population hospitalised in the Chaim Sheba Medical Center between 1990-1997.
To identify the patterns of diuretic use and the expected side effects across the entire hypertensive patients, we used the database of the General Practice Maccabi served by the Chaim Sheba Medical Center. We therefore retrieved the age and sex distribution of 5682 patients who were prescribed diuretics for hypertension during January and March of 1999. This database is not contemporaneous with the patients admitted, and it may be a source of error. However, prescriptions in Israel were not changed during these years and therefore the possible error is marginal.
Statistical analysis
Results are presented as mean ± SD. The Student's t-test was used to compare means of subgroups. The odds ratios (OR) to develop hyponatraemia were calculated for patients hospitalised for hyponatraemia (observed rates) relative to prescription data derived from the general practice database (expected rates). The Programs for Epidemiologic Analysis program CASECONT 14 was used to calculate the OR.
Results
Patients characteristics
We identified a total of 5384 patients with hyponatraemia, 5204 of whom had other possible causes for hyponatraemia and were excluded from the analysis. Thus we focus on 180 hypertensive patients with diuretic induced hyponatraemia. As Table 1 indicates, 149 of the 180 patients were women, and 90% of the patients were older than 65 years. During the same time period, 49% of all patients hospitalised in the internal wing of the Chaim Sheba Medical Center were females. The database of the general practice Maccabi in the same area showed that among 5682 patients who were prescribed diuretics for hypertension 3454 were women and 2228 were men. Age distribution of the population is depicted in Figure 1 .
Across all ages, the OR for hyponatraemia in women vs men was 3.10 (95% confidence interval (CI): 2.07-4.67). The OR for hyponatraemia in patients of both sexes older than 75 years vs those younger than 75 years was 6.62 (95% CI: 4.82-9.10). The OR for hyponatraemia in patients of both sexes older than 65 years vs those younger than 65 years was 9.87 (95% CI: 5.93-16.64). The OR for patients of both sexes older than 75 years vs those younger than 65 years was 16.64 (95% CI: 9.84 -28.47).
Type and dose of diuretics
Most patients received hydrochlorothiazide ( Table  2 ). The average daily dose of the hydrochlorothiazide was 35 ± 18 mg. Forty-four percent of the patients used a dose that was greater than 50 mg daily, and only 10% of the patients used a low dose of thiazide (12.5 mg daily).
Duration of treatment
Duration of diuretic treatment prior to the development of hyponatraemia was clearly reported in 57 patients. Hyponatraemia was diagnosed within 1 month of treatment in 44% of the patients and after more than 6 months of treatment in 45% of the patients. In 37% of the patients hyponatraemia was diagnosed within the first 10 days of treatment, whereas in 37% of the patients it was diagnosed more than a year after initiation of treatment. Those who developed hyponatraemia shortly after initiation of therapy had similar characteristics to those who developed it after 6 months (P = NS for all variables). 
Clinical and laboratory findings on admission
Weakness and vomiting were the most common complaints (Table 3) . Thirty-one patients (17.2%) were asymptomatic on admission and were referred
Journal of Human Hypertension for hospitalisation because of incidental finding of hyponatraemia. Serum sodium levels were below 110 mmol/L in 11 patients. Only three patients had serum sodium levels above 130 mmol/L (Figure 2 ). Serum potassium levels were normal (Ͼ3.5 mmol/L) in 120 patients. Six patients had elevated serum creatine kinase levels.
Associated diseases and medications
In addition to hypertension, many patients had ischaemic heart disease, diabetes mellitus and stroke (Table 4) . Patients of the subgroups did not differ in their characteristics. Many patients on diuretics also received concomitant therapy with calcium antagonists (35%), ␤-blockers (33%) and angiotensin-converting enzyme inhibitors (24%). 
Discussion
Diuretics are widely prescribed medications in hypertensive patients. In the United States alone in 1999, more than 20 million hypertensive patients were taking diuretics either as monotherapy or in combination. These drugs may cause hyponatraemia in a substantial number of patients, and hyponatraemia may even be more common than hypokalaemia. In the SHEP study, 2 4.1% of the diuretic treated patients had hyponatraemia (serum sodium of less than 130 mmol/L), and 3.9% had hypokalaemia (serum potassium of less than 3.2 mmol/L) during the study. Sunderam and Mankikar 9 found among elderly patients taking diuretics that 17% developed hyponatraemia compared with only 6.6% who developed diuretic induced hypokaemia. Given the large number of patients at risk, it is important to better characterise the subgroup of patients who are prone to developing hyponatraemia. Numerous case reports have indicated that hypertensive women are particularly at risk to develop hyponatraemia. 11, [15] [16] [17] [18] [19] [20] [21] [22] However, since hypertensive women are more often treated with diuretics than hypertensive men, 23, 24 they may be more susceptible to develop hyponatraemia. Moreover, women are more symptomatic than men at similar serum sodium levels and therefore may be diagnosed more often than men. 25 In the present study, we found that, across all ages, women have a three-fold higher risk than men to develop hyponatraemia. Siegler et al 10 found that among patients who were hospitalised in psychiatric departments, the risk to develop hyponatraemia was doubled in women. The reason that women are more susceptible to the effects of thiazide diuretics than men is unknown. It may be that women drink more than men to compensate for the diuretic and therefore develop more dilutional hyponatraemia. 26 Diuretic treatment is recommended as the drug of choice for the treatment of hypertension in the elderly, but this very subgroup of patients is more susceptible to develop hyponatraemia. Siegler et al 10 found that among inpatients who are on psychiatry service, age was significantly associated with hyponatraemia in univariate but not in multivariate analyses. Many studies indicated that the elderly are more prone to develop diuretic-induced hyponatraemia, 9, 13 but the accurate risk of elderly patients to develop hyponatraemia was not calculated. In the present study we found that patients, of both sexes, who are older than 65 years have a nine-fold greater risk to develop hyponatraemia than younger counterparts. A thiazide diuretic acting on an ageing kidney with reduced glomerular filtration rate decreases free water clearance which may result in hyponatraemia. In addition, release of antidiuretic hormone may contribute to the hyponatraemia in the elderly. 9 Hyponatraemia is said to usually develop shortly after initiation of diuretic therapy. 13, 22 However, in our study 45% of the patients were diagnosed with hyponatraemia more than 6 months after starting diuretic therapy. This observation raises the suspicion that diuretics facilitates and is not the only provocation for hyponatraemia. It appears that in a diuretic treated patient a precipitating factor such as lung infection or gastrointestinal disease may induce hyponatraemia. Therefore, close monitoring of serum electrolytes is required in all patients treated with diuretics, not only at the start of treatment. Moreover, in diuretic treated patients, any complaint of weakness, vomiting, diarrhoea or confusion should raise the suspicion of hyponatraemia. It is noteworthy that patients may develop severe hyponatraemia without any symptoms. As indicated by others, the risk of developing hyponatraemia is minimal with non thiazide-based therapy and with low-dose treatment. Siegler et al 10 showed that among inpatients who are on psychiatry service, the use of calcium antagonists and coexistence of diabetes mellitus increase the risk of developing hyponatraemia. In our study 20% of the patients had diabetes mellitus, and 35% also used calcium antagonists. Fichman et al 22 suggested that hyponatraemia results from potassium depletion which exaggerates the volume receptor release of vasopressin. However, most patients in our study did not have associated hypokalaemia. Thus, hypokalaemia does not seem to be the cause of diuretic induced hyponatraemia. Six patients in our series had elevated creatine kinase associated with hyponatraemia. We previously described a case of a patient in whom hyponatraemia not associated with rhabdomyolysis or hypothyroidism induced transient elevations of serum creatine kinase levels. 27 This association should be born in mind to prevent erroneous diagnosis of myocardial injury.
We conclude that diuretic induced hyponatraemia may be insidious and may appear even after prolonged use of diuretics. This dangerous side effect appears mainly in elderly women. Therefore, diuretics should be used in low doses only in elderly hypertensive women, and all patients should be monitored closely for serum sodium and potassium levels.
